Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Longboard Pharmaceuticals Inc (NQ: LBPH ) 36.42 UNCHANGED Streaming Delayed Price Updated: 4:00 PM EDT, Oct 2, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Headline News about Longboard Pharmaceuticals Inc < Previous 1 2 Next > Starbucks To Rally More Than 22%? Here Are 10 Top Analyst Forecasts For Wednesday September 18, 2024 Via Benzinga Longboard Pharmaceuticals Boasts High-Value Epilepsy Assets, Analyst Initiates Coverage September 10, 2024 Truist Securities initiated coverage on Longboard Pharmaceuticals, citing it as a CNS-focused biotech with high-value epilepsy assets. Via Benzinga 3 Russell 2000 Growth Stocks That Could Be Worth the Risk July 23, 2024 These three small-cap stocks could deliver hefty returns if the central bank cuts rates. Via The Motley Fool Topics Economy Exposures Interest Rates Top 3 Health Care Stocks That May Crash This Quarter July 03, 2024 Via Benzinga LBPH Stock Earnings: Longboard Pharmaceuticals Beats EPS for Q1 2024 May 02, 2024 LBPH stock results show that Longboard Pharmaceuticals beat analyst estimates for earnings per share the first quarter of 2024. Via InvestorPlace Recap: Longboard Pharmaceuticals Q4 Earnings March 12, 2024 Via Benzinga Looking Into Longboard Pharmaceuticals's Recent Short Interest January 19, 2024 Via Benzinga The Latest Analyst Ratings for Longboard Pharmaceuticals October 24, 2023 Via Benzinga The Latest Analyst Ratings for Longboard Pharmaceuticals June 27, 2023 Via Benzinga Why Intel Shares Are Trading Lower By Over 10%? Here Are Other Stocks Moving In Friday's Mid-Day Session January 26, 2024 Shares of Intel Corporation (NASDAQ: INTC) fell sharply during Friday’s session. Intel reported upbeat results for its fourth quarter, but issued a weak forecast for the first quarter. Via Benzinga Forget the "Magnificent Seven" -- This Stock Has Nearly Quadrupled in 2024, and Wall Street Thinks It Can Go a Lot Higher January 17, 2024 You might say that this biotech stock is magnificent. Via The Motley Fool Cantor Fitzgerald Maintains Overweight Rating for Longboard Pharmaceuticals: Here's What You Need To Know January 16, 2024 Via Benzinga The Latest Analyst Ratings for Longboard Pharmaceuticals May 10, 2023 Via Benzinga Recap: Longboard Pharmaceuticals Q1 Earnings May 09, 2023 Via Benzinga Citigroup Maintains Buy Rating for Longboard Pharmaceuticals: Here's What You Need To Know March 09, 2023 Via Benzinga Jim Cramer: This Energy Firm Has 'Good Growth, Good Yield' But As For IonQ? Ixnay January 04, 2024 On CNBC’s "Mad Money Lightning Round," Jim Cramer said Equitrans Midstream Corporation (NYSE: ETRN) is very solid. "Good growth, good yield. Via Benzinga Why Longboard Pharmaceuticals Stock Is Falling January 03, 2024 Longboard Pharmaceuticals Inc (NASDAQ: LBPH) shares are trading lower by 11.3% to $22.26 Wednesday afternoon after the company announced that it commenced a $150 million underwritten public offering... Via Benzinga Apple, Longboard Pharmaceuticals, Coinbase, Moderna, Tesla: Why These 5 Stocks Are On Investors' Radars Today January 02, 2024 U.S. stocks experienced mixed results in Tuesday’s trading session. The Dow Jones index showed resilience, gaining around 25 points, a modest rise of 0.07% to 37,715.04. In contrast, the tech-heavy... Via Benzinga Topics Stocks Exposures US Equities Why Longboard Pharma Catapulted 316%, Leading A Biotech Stock Rally January 02, 2024 Longboard Pharmaceuticals is working on treatments for seizure disorders. Via Investor's Business Daily Crude Oil Down 2%; Tesla Deliveries Top Estimates January 02, 2024 U.S. stocks traded mostly lower toward the end of trading, with the Nasdaq Composite falling more than 250 points on Tuesday. The Dow traded up 0.01% to 37,691.77 while the NASDAQ fell 1.78% to... Via Benzinga Topics Stocks Exposures Fossil Fuels US Equities There's Optimism Around Longboard Pharmaceuticals' Anti-Seizure Candidate: Analyst Boosts Price Target January 02, 2024 Tuesday, Longboard Pharmaceuticals Inc (NASDAQ: LBPH) released topline data from the PACIFIC Phase 1b/2a study evaluating bexicaserin (LP352) for seizures associated with a broad range of... Via Benzinga Why Longboard Pharmaceuticals Shares Are Trading Higher By Around 200%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session January 02, 2024 Shares of Longboard Pharmaceuticals, Inc. Via Benzinga Why Is Longboard Pharmaceuticals (LBPH) Stock Up 175% Today? January 02, 2024 With Longboard Pharmaceuticals delivering positive clinical trial data, LBPH stock soared on the positive therapeutic implications. Via InvestorPlace 12 Health Care Stocks Moving In Tuesday's Intraday Session January 02, 2024 Via Benzinga Dow Turns Higher; Anavex Life Sciences Shares Plunge January 02, 2024 U.S. stocks traded mixed midway through trading, with the Dow Jones index gaining around 50 points on Tuesday. The Dow traded up 0.13% to 37,739.18 while the NASDAQ fell 1.29% to 14,818.23. The S&P 500... Via Benzinga Topics Stocks Exposures US Equities Neurology-Focused Longboard Pharmaceuticals' Stock Soars Over 200% Today - Here's Why January 02, 2024 Longboard Pharmaceuticals Inc (NASDAQ: LBPH) released topline data from the PACIFIC Phase 1b/2a study evaluating bexicaserin (LP352) for seizures associated with a broad range of Developmental Via Benzinga Dow Down 100 Points; US Manufacturing PMI Falls In December January 02, 2024 U.S. stocks traded lower this morning, with the Dow Jones index falling more than 100 points on Tuesday. Following the market opening Tuesday, the Dow traded down 0.28% to 37,584.41 while the NASDAQ... Via Benzinga Topics Stocks Exposures US Equities 12 Health Care Stocks Moving In Tuesday's Pre-Market Session January 02, 2024 Via Benzinga Benzinga's Top Ratings Upgrades, Downgrades For April 27, 2023 April 27, 2023 Via Benzinga Top 5 Health Care Stocks That Could Sink Your Portfolio This Quarter April 27, 2023 The most overbought stocks in the health care sector presents an opportunity to go short on these overvalued companies. Via Benzinga < Previous 1 2 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.